| Name: | Axitinib Impurity F |
| Catalogue No. | VL4110007 |
| CAS No. | 1443118-73-7 |
| Molecular Formula | C22H20N4OS |
| Molecular Weight | 388.49 |
| Status | In-stock |
| IUPAC Name | N-methyl-2-((3-(2-(pyridin-2-yl)ethyl)-1H-indazol-6-yl)thio)benzamide |
| Description | Axitinib Impurity F(CAS No: 1443118-73-7) or N-methyl-2-((3-(2-(pyridin-2-yl)ethyl)-1H-indazol-6-yl)thio)benzamide, Axitinib Impurity F is an impurity of Axitinib, a second-generation targeted drug, is a potent and highly selective inhibitor of vascular endothelial growth factor receptor and is used to treatment of renal cell carcinoma |
| References | Sonpavde, Guru, et al. “Axitinib for Renal Cell Carcinoma.” Expert Opinion on Investigational Drugs, vol. 17, no. 5, 30 Apr. 2008, pp. 741–748, 10.1517/13543784.17.5.741. |
